000170484 001__ 170484
000170484 005__ 20240229133715.0
000170484 0247_ $$2doi$$a10.1186/s13195-021-00889-2
000170484 0247_ $$2pmid$$apmid:34461995
000170484 0247_ $$2altmetric$$aaltmetric:112641525
000170484 037__ $$aDKFZ-2021-01965
000170484 041__ $$aEnglish
000170484 082__ $$a610
000170484 1001_ $$0P:(DE-He78)6cc3cc35505b446fde081e7cd89a4b87$$aMöllers, Tobias$$b0$$eFirst author$$udkfz
000170484 245__ $$aAβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood.
000170484 260__ $$aLondon$$bBioMed Central$$c2021
000170484 3367_ $$2DRIVER$$aarticle
000170484 3367_ $$2DataCite$$aOutput Types/Journal article
000170484 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637227685_30448
000170484 3367_ $$2BibTeX$$aARTICLE
000170484 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000170484 3367_ $$00$$2EndNote$$aJournal Article
000170484 500__ $$a#EA:C070#LA:C070#
000170484 520__ $$aTo understand the potential for early intervention and prevention measures in Alzheimer's disease, the association between risk factors and early pathological change needs to be assessed. Hence, the aim of this study was to determine whether risk factors of Alzheimer's clinical syndrome (clinical AD), such as body mass index (BMI), are associated with Aβ misfolding in blood, a strong risk marker for AD among older adults.Information on risk factors and blood samples were collected at baseline in the ESTHER study, a population-based cohort study of older adults (age 50-75 years) in Germany. Aβ misfolding in blood plasma was analyzed using an immuno-infrared-sensor in a total of 872 participants in a nested case-control design among incident dementia cases and matched controls. Associations between risk factors and Aβ misfolding were assessed by multiple logistic regression. For comparison, the association between the risk factors and AD incidence during 17 years of follow-up was investigated in parallel among 5987 cohort participants.An inverse association with Aβ misfolding was seen for BMI at age 50 based on reported weight history (aOR 0.64, 95% CI 0.43-0.96, p = 0.03). Similar but not statistically significant associations were seen for BMI at baseline (i.e., mean age 68) and at age 40. No statistically significant associations with Aβ misfolding were found for other risk factors, such as diabetes, smoking, and physical activity. On the other hand, low physical activity was associated with a significantly reduced risk of developing clinical AD compared to physical inactivity.Our results support that AD pathology may be detectable and associated with reduced weight even in middle adulthood, many years before clinical diagnosis of AD. Physical activity might reduce the risk of onset of AD symptoms.
000170484 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000170484 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000170484 650_7 $$2Other$$aAlzheimer’s disease
000170484 650_7 $$2Other$$aAmyloid beta misfolding
000170484 650_7 $$2Other$$aBMI
000170484 650_7 $$2Other$$acohort study
000170484 7001_ $$0P:(DE-He78)104fae0755c89365b7ae32238b3f1f52$$aStocker, Hannah$$b1$$udkfz
000170484 7001_ $$0P:(DE-He78)d9d72431035d8535d1b65ce9a01c2f60$$aPerna, Laura$$b2$$udkfz
000170484 7001_ $$aNabers, Andreas$$b3
000170484 7001_ $$aRujescu, Dan$$b4
000170484 7001_ $$aHartmann, Annette M$$b5
000170484 7001_ $$aHolleczek, Bernd$$b6
000170484 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b7$$udkfz
000170484 7001_ $$aGerwert, Klaus$$b8
000170484 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b9$$eLast author$$udkfz
000170484 773__ $$0PERI:(DE-600)2506521-X$$a10.1186/s13195-021-00889-2$$gVol. 13, no. 1, p. 145$$n1$$p145$$tAlzheimer's research & therapy$$v13$$x1758-9193$$y2021
000170484 909CO $$ooai:inrepo02.dkfz.de:170484$$pVDB
000170484 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6cc3cc35505b446fde081e7cd89a4b87$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000170484 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)104fae0755c89365b7ae32238b3f1f52$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000170484 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d9d72431035d8535d1b65ce9a01c2f60$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000170484 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000170484 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000170484 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000170484 9141_ $$y2021
000170484 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS RES THER : 2019$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2021-05-04
000170484 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bALZHEIMERS RES THER : 2019$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000170484 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000170484 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000170484 980__ $$ajournal
000170484 980__ $$aVDB
000170484 980__ $$aI:(DE-He78)C070-20160331
000170484 980__ $$aUNRESTRICTED